# A transdisciplinary framework for managing metabolic dysfunction associated steatotic liver disease

**Authors:** Sania Kouser, Sanketh V. Sharma, Arun Bhanu, Subrahmanya Kumar Kukkupuni, Chethala N. Vishnuprasad

PMC · DOI: 10.3389/fphar.2026.1767844 · Frontiers in Pharmacology · 2026-02-24

## TL;DR

This paper proposes a new approach to managing liver disease by combining traditional and modern medicine for better health outcomes.

## Contribution

A novel transdisciplinary framework integrating traditional medicine and modern biomedicine for managing MASLD.

## Key findings

- A transdisciplinary framework is proposed for managing MASLD by integrating traditional and modern medicine.
- The framework includes dual-diagnostic workflows and stage-adaptive management algorithms for personalized care.
- The model emphasizes health restoration and long-term wellness over traditional disease treatment.

## Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly emerging as a public health issue across the globe. Its complex etiopathology and association with diverse comorbidities poses significant challenges to conventional pharmacological drugs derived from the “lock-and-key” paradigm of pharmacology. To overcome the challenges of complexity and non-linear dynamics underlying the disease biology of MASLD, this article proposes a transdisciplinary framework combining holistic disease management principles of traditional medicines with molecular precision of modern biomedicine. Ayurveda - an exceptionally designed and widely practiced Indian Systems of Medicine (ISM) - is explored as a representative model for this framework. This article outlines a unified, biologically plausible transdisciplinary approach incorporating dual-diagnostic workflows, integrative decision interface, and stage-adaptive management algorithm for prevention, early intervention, and advanced disease care. The framework emphasizes integrative and personalized strategies integrating nutrition, lifestyle modification and drug interventions, harnessing the molecular precision of biomedicine alongside the systemic effects of phytochemical diversity. The transdisciplinary model seeks to shift the focus from ‘disease treatment’ to ‘health restoration’ and long-term wellness. The article highlights the scopes and challenges of this framework to offer more comprehensive, sustainable, and patient-centred solutions for MASLD.

## Linked entities

- **Diseases:** metabolic dysfunction-associated steatotic liver disease (MONDO:0013209), MASLD (MONDO:0013209)

## Full-text entities

- **Diseases:** metabolic dysfunction (MESH:D008659), MASLD (MESH:D008107)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971720/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971720/full.md

## References

130 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971720/full.md

---
Source: https://tomesphere.com/paper/PMC12971720